Himalaya Boswellia (Shallaki) Review

Yes — Shallaki is boswellia's traditional Ayurvedic name. Boswellia serrata has been used in Ayurvedic medicine for inflammatory conditions for centuries, where it's known as Shallaki (or Salai Guggul). Himalaya, an Indian brand with deep roots in Ayurvedic botanicals, sells it under that traditional name. So when you buy Himalaya Shallaki, you're buying a standardised Boswellia serrata extract — the same botanical as every other pick on this list — from a company that has worked with it in its original traditional context far longer than most Western supplement brands have existed.

It's a standardised extract, not raw whole-herb powder — which is what earns it a place on this list. Himalaya standardises the Shallaki extract and applies botanical identity testing, so you're getting characterised material rather than unverified resin. The limitation is the same as the other mid-tier picks: it standardises to the extract generally rather than to a stated AKBA percentage or a named clinical fraction like 5-Loxin. So it's genuinely standardised and well-identified, just not AKBA-enriched to the precision the strongest trial used.

Two caplets a day is typical, taken with food. At that dose the 60-caplet bottle is roughly a one-month supply — shorter runway than the 100-120 count capsule competitors, and the caplet format gives a bit less dosing flexibility than capsules you could, in principle, open. Start at the label serving for two to four weeks; adjust within the labelled range if your response is partial. The one-month bottle means more frequent reorders than Swanson or Double Wood.

Primarily for the traditional-medicine sourcing context and the brand's botanical heritage. Himalaya has worked with boswellia (Shallaki) in its Ayurvedic context for decades, with genuine expertise in the botanical and solid identity testing — if that provenance matters to you, it's a meaningful differentiator. On the pure numbers, though, it's comparable to the other mid-tier standardised whole extracts: same AKBA precision gap, similar dose alignment. So you'd choose it for the heritage story and the trusted name, not because it outperforms NOW or Pure Encapsulations on standardisation precision.

Yes — Himalaya manufactures under GMP certification and applies botanical identity testing, which is genuinely valuable for an Ayurvedic herb where correct species identification and sourcing matter. The company has deep expertise in botanicals and a long track record. For an adulteration-prone category, identity-tested, GMP-made standardised material from a brand with this botanical heritage is a reasonable quality floor. The testing is a real strength; it's the AKBA-precision tier where the bottle sits behind the enriched picks.

The buyer who values the traditional-medicine sourcing story and wants a trusted botanical-heritage name behind their boswellia. For someone drawn to the Ayurvedic context — or who already trusts Himalaya's botanicals — it's a competent, well-made, fairly-priced standardised extract with genuine provenance. It's NOT the best pick if you want a named AKBA-enriched extract at its trial dose (Life Extension Boswellia #1), the longest runway or lowest price (Swanson #5, Nutricost #6), or a boswellia-plus-curcumin combo (Terry Naturally Curamin #2). Buy it for the heritage and the trusted name.

1. [1] Kimmatkar 2003 PMID 12622457 — Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — a randomized double blind placebo controlled trial. Randomised, double-blind, placebo-controlled crossover trial in knee-osteoarthritis patients: a standardised Boswellia serrata extract significantly reduced knee pain, improved function, and increased walking distance versus placebo over 8 weeks. Modern evidence supporting the joint benefit of standardised Shallaki / boswellia extract.
2. [2] Sengupta 2008 PMID 18667054 — A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Placebo-controlled trial of 5-Loxin (an AKBA-enriched Boswellia extract, ~30% AKBA) at 100 and 250 mg/day in knee osteoarthritis: significant, dose-related pain and function improvements, with relief within ~7 days at 250 mg. Defines the AKBA-enriched precision tier that Himalaya's standardised Shallaki extract sits below.